MIRA MIRA Pharmaceuticals, Inc. - Common Stock
$0,95
Preço · Mai 20, 2026
Fundamentais a partir de Mai 14, 2026
Intervalo 52 Semanas
$1–$2
3% of range
Classificação do Analista
BUY
7 analysts
Preço-Alvo
—
P/E (TTM)
-1.1
ROE
-190.5%
Margem de Lucro Líquido
-10557.5%
MIRA Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$0.95
Capitalização de Mercado
$63M
P/E (TTM)
-1.1
EPS (TTM)
$-1.35
Receita (TTM)
—
Rendimento div.
—
ROE
-190.5%
Dívida/Capital
—
Intervalo 52 Semanas
$1 – $2
MIRA Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Configure
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita e Lucro Líquido
—
EPS
$-1.35
2022-12-31
→
2025-12-31
Fluxo de caixa livre
—
Margens
-10557.5%
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Métrica
Tendência de 5 anos
MIRA
Mediana de Pares
P/E (TTM)
-1.1
42.1
P/B
6.1
3.1
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Métrica
Tendência de 5 anos
MIRA
Mediana de Pares
Net Profit Margin (Margem de Lucro Líquido)
-10557.5%
-503.2%
ROA
-149.0%
-48.3%
ROE
-190.5%
-85.5%
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Métrica
Tendência de 5 anos
MIRA
Mediana de Pares
Current Ratio (Índice de liquidez corrente)
15.8
2.8
Quick Ratio (Índice de Liquidez Seca)
15.7
—
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Métrica
Tendência de 5 anos
MIRA
Mediana de Pares
Revenue YoY (Receita Ano a Ano)
-40.3%
—
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Métrica
Tendência de 5 anos
MIRA
Mediana de Pares
MIRA Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
COMPRA
7 analistas
- Compra forte 2 28,6%
- Compra 4 57,1%
- Manter 1 14,3%
- Venda 0 0,0%
- Venda forte 0 0,0%
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
0.05%
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 30 de Setembro de 2025 | $-0.06 | $-0.08 | 0.02% |
| 30 de Junho de 2025 | $-0.09 | $-0.13 | 0.04% |
| 31 de Março de 2025 | $-0.11 | $-0.15 | 0.04% |
| 31 de Dezembro de 2024 | $-0.15 | $-0.24 | 0.09% |
Comparação com pares Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| MIRA | $63M | -1.1 | -40.3% | -10557.5% | -190.5% | — |
| SCLX | — | — | — | — | — | — |
| TLPH | $56M | — | — | -51035.7% | -120.8% | — |
| NTRB | — | — | — | — | — | — |
| GRCE | — | -2.9 | — | — | -16.1% | — |
| TVRD | $40M | -1.3 | -66.0% | — | -67.6% | — |
| DARE | $28M | -1.6 | 10429.4% | -1300.7% | 270.9% | — |
| GRCE | — | -2.9 | — | — | -16.1% | — |
| VERU | $56M | -5.4 | 3.6% | — | -115.4% | — |
| QCLS | — | -0.5 | — | — | — | — |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 10
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| R&D Expense | $2M | $3M | $2M | $2M | |
| SG&A Expense | $9M | $5M | $6M | $3M | |
| Operating Expenses | $10M | $8M | $9M | $7M | |
| Interest Expense | · | $-165.7K | $3M | $10.2K | |
| Other Non-op | $50.6K | $165.7K | · | · | |
| Net Income | $-10M | $-8M | $-12M | $-7M | |
| EPS (Basic) | $-1.35 | $-0.51 | $-0.85 | $-0.40 | |
| EPS (Diluted) | $-1.35 | $-0.51 | $-0.85 | $-0.40 | |
| Shares (Basic) | 23,694,333 | 15,444,149 | 13,924,619 | 17,566,533 | |
| Shares (Diluted) | · | 15,444,149 | 13,924,619 | 17,566,533 |
Balanço Patrimonial 16
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $6M | $3M | $5M | $351.0K | |
| Short-term Investments | $5M | · | · | · | |
| Prepaid Expense | $28.1K | $54.7K | $243.8K | · | |
| Current Assets | $11M | $3M | $5M | $494.4K | |
| Total Assets | $11M | $3M | $5M | $858.1K | |
| Accounts Payable | $129.2K | $723.3K | $538.6K | $811.7K | |
| Accrued Liabilities | · | $300.0K | · | · | |
| Current Liabilities | $702.1K | $723.3K | $558.1K | $1M | |
| Capital Leases | · | · | · | $84.3K | |
| Total Liabilities | $702.1K | $723.3K | $558.1K | $1M | |
| Common Stock | $4.2K | $1.7K | $1.5K | $6.7K | |
| Paid-in Capital | $50M | $31M | $26M | $9M | |
| Retained Earnings | $-40M | $-29M | $-21M | $-9M | |
| Stockholders' Equity | $10M | $2M | $4M | $-596.2K | |
| Liabilities + Equity | $11M | $3M | $5M | $858.1K | |
| Shares Outstanding | 41,938,587 | 16,560,852 | 14,780,885 | 13,313,000 |
Fluxo de Caixa 6
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $6M | $2M | $3M | $1M | |
| Operating Cash Flow | $-5M | $-6M | $-5M | $-6M | |
| Stock Issued | $7M | $4M | $8M | $3M | |
| Net Stock Activity | $7M | · | $8M | · | |
| Financing Cash Flow | $8M | $4M | $9M | $3M | |
| Net Change in Cash | $4M | $-2M | $4M | $-2M |
Lucratividade 3
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Net Margin | -10557.5% | · | · | · | |
| ROA | -149.0% | · | -413.9% | · | |
| ROE | -190.5% | · | -634.3% | · |
Liquidez e Solvência 2
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 15.8 | · | 8.7 | · | |
| Quick Ratio | 15.7 | · | 8.2 | · |
Eficiência 1
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | · |
Taxas de Crescimento 1
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | -40.3% | · | · | · |
Avaliação (TTM) 7
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Net Income TTM | $-10M | $-8M | $-12M | · | |
| Market Cap | $63M | · | $16M | · | |
| P/E | -1.1 | -2.2 | -1.2 | · | |
| P/B | 6.1 | · | 3.5 | · | |
| P / Tangible Book | 6.1 | 8.6 | 3.5 | · | |
| P / Cash Flow | -13.6 | · | -3.4 | · | |
| Earnings Yield | -89.4% | -44.7% | -81.0% | · |
Demonstração de Resultados 10
| Métrica | Tendência | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $524.8K | $496.5K | $412.6K | $496.2K | $314.4K | $861.4K | $1M | $614.5K | $762.3K | $387.1K | $1M | $-101.0K | $884.8K | |
| SG&A Expense | $578.7K | $5M | $904.3K | $1M | $1M | $2M | $1M | $1M | $1M | $3M | $2M | $1M | $51.7K | |
| Operating Expenses | $1M | $6M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $970.2K | $1M | |
| Interest Expense | · | · | · | · | $-21.4K | · | $-37.8K | $-39.4K | $-50.4K | $3M | $427.7K | $295.9K | $1.8K | |
| Other Non-op | $-46.7K | $-158.5K | $179.3K | $-107 | $21.4K | $38.1K | $37.8K | · | · | · | · | · | · | |
| Net Income | $-1M | $-6M | $-1M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-6M | $-4M | $-1M | $-1M | |
| EPS (Basic) | $-0.03 | $0.03 | $-1.18 | $-0.09 | $-0.11 | $-0.11 | $-0.14 | $-0.11 | $-0.15 | $-0.39 | $-0.26 | $-0.10 | $0.03 | |
| EPS (Diluted) | $-0.03 | $0.03 | $-1.18 | $-0.09 | $-0.11 | $-0.11 | $-0.14 | $-0.11 | $-0.15 | $-0.39 | $-0.26 | $-0.10 | $0.03 | |
| Shares (Basic) | 41,941,370 | -29,212,221 | 19,274,947 | 16,986,488 | 16,645,119 | -29,189,536 | 15,071,915 | 14,780,885 | 14,780,885 | -30,778,245 | 13,639,197 | 13,313,000 | 4,400,333 | |
| Shares (Diluted) | · | · | 19,274,947 | 16,986,488 | 16,645,119 | · | 15,071,915 | 14,780,885 | 14,780,885 | -30,778,245 | 13,639,197 | 13,313,000 | 4,400,333 |
Balanço Patrimonial 16
| Métrica | Tendência | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $6M | $3M | $730.5K | $1M | $3M | $4M | $3M | $4M | $5M | $6M | $24.8K | $351.0K | |
| Short-term Investments | $5M | $5M | $5M | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $21.7K | $28.1K | $61.9K | $102.4K | $158.6K | $54.7K | $86.6K | $108.6K | $185.3K | $243.8K | $202.8K | $42.5K | · | |
| Current Assets | $9M | $11M | $8M | $832.9K | $1M | $3M | $4M | $3M | $4M | $5M | $6M | $420.7K | $494.4K | |
| Total Assets | $9M | $11M | $8M | $868.3K | $1M | $3M | $4M | $3M | $4M | $5M | $9M | $4M | $858.1K | |
| Accounts Payable | $34.0K | $129.2K | $83.9K | $298.5K | $100.7K | $723.3K | $692.8K | $782.1K | $636.3K | $538.6K | $779.6K | $659.1K | $811.7K | |
| Accrued Liabilities | · | · | · | · | $5.5K | · | · | · | · | · | · | · | · | |
| Current Liabilities | $114.8K | $702.1K | $83.9K | $298.5K | $106.2K | $723.3K | $692.8K | $796.6K | $652.0K | $558.1K | $868.4K | $3M | $1M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | $34.5K | $51.5K | $84.3K | |
| Total Liabilities | $114.8K | $702.1K | $83.9K | $298.5K | $106.2K | $723.3K | $692.8K | $796.6K | $652.0K | $558.1K | $902.9K | $3M | $1M | |
| Common Stock | $4.2K | $4.2K | $4.0K | $1.7K | $1.7K | $1.7K | $1.6K | $1.5K | $1.5K | $1.5K | $1.5K | $6.7K | $6.7K | |
| Paid-in Capital | $50M | $50M | $41M | $33M | $32M | $31M | $30M | $27M | $26M | $26M | $24M | $13M | $9M | |
| Retained Earnings | $-41M | $-40M | $-34M | $-32M | $-31M | $-29M | $-27M | $-25M | $-23M | $-21M | $-15M | $-12M | $-9M | |
| Stockholders' Equity | $9M | $10M | $8M | $569.9K | $1M | $2M | $4M | $2M | $3M | $4M | $8M | $1M | $-596.2K | |
| Liabilities + Equity | $9M | $11M | $8M | $868.3K | $1M | $3M | $4M | $3M | $4M | $5M | $9M | $4M | $858.1K | |
| Shares Outstanding | 42,022,087 | 41,938,587 | 39,511,492 | 17,385,140 | 16,813,654 | 16,560,852 | 16,266,148 | 14,780,885 | 14,780,885 | 14,780,885 | 14,780,885 | 13,313,000 | 13,313,000 |
Fluxo de Caixa 6
| Métrica | Tendência | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $107.6K | $5M | $390.8K | $489.6K | $874.8K | $546.8K | $269.0K | $604.8K | $500.2K | $213.8K | $1M | $737.2K | $147.8K | |
| Operating Cash Flow | $-1M | $-1M | $-1M | $-799.7K | $-2M | $-2M | $-2M | $-863.9K | $-1M | $-1M | $-2M | $-660.8K | $-975.4K | |
| Stock Issued | · | $4M | $3M | $345.3K | $3.4K | $478.9K | · | · | · | $0 | · | · | $285.0K | |
| Net Stock Activity | · | · | · | · | $3.4K | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-330.6K | $5M | $3M | $323.8K | $3.4K | $493.4K | $3M | $159.0K | $-24.3K | $-230.7K | $8M | $684.3K | $1M | |
| Net Change in Cash | $-2M | $4M | $2M | $-475.8K | $-2M | $-1M | $1M | $-704.9K | $-1M | $-1M | $6M | $23.5K | $163.6K |
Lucratividade 3
| Métrica | Tendência | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | -2561.1% | · | -7247.7% | · | · | · | · | · | · | · | · | · | · | |
| ROA | -21.2% | · | -19.1% | -79.2% | -68.5% | · | -30.8% | -49.5% | -90.2% | · | -79.6% | -66.2% | · | |
| ROE | -21.6% | · | -20.5% | -110.3% | -80.2% | · | -35.0% | -99.0% | -108.8% | · | -88.4% | -211.6% | · |
Liquidez e Solvência 2
| Métrica | Tendência | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 82.2 | · | 90.5 | 2.8 | 12.9 | · | 6.1 | 3.7 | 5.7 | · | 7.0 | 0.2 | · | |
| Quick Ratio | 82.0 | · | 89.8 | 2.4 | 11.4 | · | 6.0 | 3.5 | 5.4 | · | 6.8 | 0.0 | · |
Eficiência 1
| Métrica | Tendência | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | · | · | · | · | · | · | · | · | · | · |
Avaliação (TTM) 7
| Métrica | Tendência | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-6M | · | $-7M | $-7M | $-7M | · | $-9M | $-8M | $-8M | · | $-8M | $-7M | · | |
| Market Cap | $45M | · | $54M | $21M | $16M | · | $21M | $9M | $16M | · | $69M | · | · | |
| P/E | -0.8 | · | -0.9 | -2.7 | -1.9 | · | -2.0 | -1.0 | -1.8 | · | -7.8 | · | · | |
| P/B | 4.8 | · | 7.1 | 36.9 | 12.7 | · | 5.9 | 4.2 | 5.2 | · | 8.5 | · | · | |
| P / Tangible Book | 4.8 | · | 7.1 | 36.9 | 12.7 | · | 5.9 | 4.2 | 5.2 | · | 8.5 | · | · | |
| P / Cash Flow | -37.4 | · | · | · | -10.1 | · | · | · | -15.5 | · | · | · | · | |
| Earnings Yield | -131.8% | · | -111.8% | -37.2% | -52.0% | · | -50.8% | -97.3% | -55.5% | · | -12.9% | · | · |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Lucro líquido | $-10M | $-8M | $-12M | $-7M |
| EPS Diluído | $-1.35 | $-0.51 | $-0.85 | $-0.40 |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Índice de liquidez corrente | 15.8 | — | 8.7 | — |
| Índice de Liquidez Seca | 15.7 | — | 8.2 | — |
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
📊
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.